On the specific treatment of asthenic states: focus on sulbutiamine

Author:

Bykov Yuri V.ORCID,Bekker Roman A.ORCID

Abstract

In this article, we try to present the available data regarding the pharmacokinetics and pharmacodynamics of sulbutiamine (Enerion), the mechanisms of its anti-asthenic action. Then we analyze and summarize the available evidence base considering the efficacy and safety of Enerion for the treatment of asthenic syndromes. Then we compare Enerion with some other drugs. The results of our review indicate the high efficacy and safety of sulbutiamine in the treatment of asthenia. Our results also show that Enerion has some clinically relevant advantages over all alternatives we reviewed there.

Publisher

Consilium Medicum

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice

Reference30 articles.

1. Морозов П.В. Новое в лечение астении. Психиатрия и психофармакотерапия. 2005;3(7):154-9 [Morozov PV. New in the treatment of asthenia. Psychiatry and Ppsychopharmacotherapy. 2005;3(7):154-9 (in Russian)].

2. Чутко Л.С. Астенические расстройства в клинической практике. Медицинский совет. 2011;9-10:104-7 [Chutko LS. Asthenic disorders in clinical practice. Meditsinskiy sovet = Medical Council. 2011;9-10:104-107 (in Russian)].

3. Петрова Н.Н., Морозов П.В., Маркин А.В., и др. Пандемия COVID-19: актуальные вызовы времени, а также новейшие данные к вопросу рационального выбора психофармакотерапии у пациентов с SARS-CoV-2. Психиатрия и психофармакотерапия. 2020;6(22):8-24 [Petrova NN, Morozov PV, Markin AV, et al. The COVID-19 pandemic: current challenges of the time, as well as the latest data on the rational choice of psychopharmacotherapy in patients with SARS-CoV-2. Psychiatry and Psychopharmacotherapy. 2020;6(22):8-24 (in Russian)].

4. Воробьева А.А. Астенические состояния: эффективная и безопасная терапия. Русский медицинский журнал. 2009;20(17):1330-3 [Vorobyeva AA. Asthenic conditions: effective and safe therapy. Russian Medical Journal. 2009;20(17):1330-3 (in Russian)].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3